Type your tag names separated by a space and hit enter

    Raltegravir

    Paul A. Pham, Pharm.D. BCPS, Alice Jenh Hsu, Pharm.D.
    Raltegravir is a topic covered in the Johns Hopkins ABX Guide.

    To view the entire topic, please or purchase a subscription.

    Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

    Johns Hopkins Guides

    -- The first section of this topic is shown below --

    INDICATIONS

    FDA

    • Treatment of HIV-1 infection in combination with other ARV agents in ART-experienced pts with evidence of HIV replication despite ongoing ART.
    • Treatment of HIV-1 infection in combination with other ARV agents in ART-naive pts.

    NON-FDA APPROVED USES

    • Substitution for other ARV agents due to drug toxicity or intolerance in pts on suppressive regimen (limited data)

    -- To view the remaining sections of this topic, please or purchase a subscription --

    Last updated: July 11, 2014

    Citation

    * When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
    TY - ELEC T1 - Raltegravir ID - 540471 A1 - ,, AU - Hsu,Alice,Pharm.D. AU - Pham,Paul,Pharm.D. BCPS Y1 - 2014/07/11/ BT - Johns Hopkins ABX Guide UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540471/all/Raltegravir PB - The Johns Hopkins University DB - Johns Hopkins Guide DP - Unbound Medicine ER -